199 related articles for article (PubMed ID: 34225603)
1. Endometrial Cancer: Genetic, Metabolic Characteristics, Therapeutic Strategies and Nanomedicine.
Cai Y; Wang B; Xu W; Liu K; Gao Y; Guo C; Chen J; Kamal MA; Yuan C
Curr Med Chem; 2021; 28(42):8755-8781. PubMed ID: 34225603
[TBL] [Abstract][Full Text] [Related]
2. Endometrial neoplasia: prognostic significance of ploidy status.
Evans MP; Podratz KC
Clin Obstet Gynecol; 1996 Sep; 39(3):696-706. PubMed ID: 8862893
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced factor-1α in endometrial carcinoma: a mini-review of current evidence.
Dousias V; Vrekoussis T; Navrozoglou I; Paschopoulos M; Stefos T; Makrigiannakis A; Jeschke U
Histol Histopathol; 2012 Oct; 27(10):1247-53. PubMed ID: 22936443
[TBL] [Abstract][Full Text] [Related]
4. Expression of programmed death-ligand 1 and hypoxia-inducible factor-1α proteins in endometrial carcinoma.
Tawadros AIF; Khalafalla MMM
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1063-S1069. PubMed ID: 30539847
[TBL] [Abstract][Full Text] [Related]
5. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Dysfunctions in Type I Endometrial Carcinoma: Exploring Their Role in Oncogenesis and Tumor Progression.
Musicco C; Cormio G; Pesce V; Loizzi V; Cicinelli E; Resta L; Ranieri G; Cormio A
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018222
[TBL] [Abstract][Full Text] [Related]
7. Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study.
Lupini L; Scutiero G; Iannone P; Martinello R; Bassi C; Ravaioli N; Soave I; Bonaccorsi G; Lanza G; Gafà R; Loizzi V; Negrini M; Greco P
Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13137. PubMed ID: 31412428
[TBL] [Abstract][Full Text] [Related]
8. Increased hypoxia-inducible factor-1α in striated muscle of tumor-bearing mice.
Devine RD; Bicer S; Reiser PJ; Wold LE
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1154-H1162. PubMed ID: 28341633
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma.
Xu JY; Zhu WJ; Cao XZ; Li XF; Wu J
Int J Gynecol Cancer; 2011 Apr; 21(3):430-4. PubMed ID: 21436690
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K; Yanokura M; Iida M; Masuda K; Aoki D
J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
[TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
12. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
Inoue M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
[TBL] [Abstract][Full Text] [Related]
13. Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.
Jones A; Teschendorff AE; Li Q; Hayward JD; Kannan A; Mould T; West J; Zikan M; Cibula D; Fiegl H; Lee SH; Wik E; Hadwin R; Arora R; Lemech C; Turunen H; Pakarinen P; Jacobs IJ; Salvesen HB; Bagchi MK; Bagchi IC; Widschwendter M
PLoS Med; 2013 Nov; 10(11):e1001551. PubMed ID: 24265601
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma.
Feng Z; Gan H; Cai Z; Li N; Yang Z; Lu G; Chen J
Jpn J Clin Oncol; 2013 Apr; 43(4):396-403. PubMed ID: 23372184
[TBL] [Abstract][Full Text] [Related]
15. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings.
Liew PL; Huang RL; Wu TI; Liao CC; Chen CW; Su PH; Wang HC; Weng YC; Lai HC
Clin Epigenetics; 2019 Nov; 11(1):170. PubMed ID: 31779688
[TBL] [Abstract][Full Text] [Related]
16. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.
Szubert M; Kozirog E; Wilczynski J
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206475
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Proline Hydroxylase 2 and Upregulation of Hypoxia-Inducible Factor 1α are Associated with Endometrial Cancer Aggressiveness.
Zhu C; Ding H; Yang J; Zhou Y; Luo Y; Shi S; Zhang Y; Wei Y; Ni G
Cancer Manag Res; 2019; 11():9907-9912. PubMed ID: 31819628
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and Clinicopathological Significance of Hypoxia-Inducible Factor-1α in Endometrial Cancer: A Meta-Analysis.
Zhu P; Shen L; Ren Q; Zeng Q; He X
Front Oncol; 2020; 10():587420. PubMed ID: 33304847
[TBL] [Abstract][Full Text] [Related]
19. PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer.
Miyasaka A; Oda K; Ikeda Y; Sone K; Fukuda T; Inaba K; Makii C; Enomoto A; Hosoya N; Tanikawa M; Uehara Y; Arimoto T; Kuramoto H; Wada-Hiraike O; Miyagawa K; Yano T; Kawana K; Osuga Y; Fujii T
Gynecol Oncol; 2015 Jul; 138(1):174-80. PubMed ID: 25913131
[TBL] [Abstract][Full Text] [Related]
20. Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer.
Koda M; Sulkowska M; Wincewicz A; Kanczuga-Koda L; Musiatowicz B; Szymanska M; Sulkowski S
Ann N Y Acad Sci; 2007 Jan; 1095():90-8. PubMed ID: 17404022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
